Wall Street brokerages predict that RTI Surgical, Inc. (NASDAQ:RTIX) will announce $0.01 earnings per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for RTI Surgical’s earnings, with the lowest EPS estimate coming in at $0.01 and the highest estimate coming in at $0.02. The company is scheduled to report its next quarterly earnings report on Wednesday, July 26th.

On average, analysts expect that RTI Surgical will report full year earnings of $0.07 per share for the current financial year, with EPS estimates ranging from $0.06 to $0.08. For the next year, analysts expect that the business will report earnings of $0.13 per share, with EPS estimates ranging from $0.10 to $0.15. Zacks’ earnings per share averages are a mean average based on a survey of sell-side analysts that cover RTI Surgical.

RTI Surgical (NASDAQ:RTIX) last released its quarterly earnings data on Thursday, April 27th. The medical equipment provider reported ($0.05) EPS for the quarter. The business had revenue of $69.90 million for the quarter, compared to analysts’ expectations of $67.68 million. RTI Surgical had a negative net margin of 6.85% and a positive return on equity of 1.34%. The company’s quarterly revenue was up 3.7% on a year-over-year basis. During the same period last year, the business earned $0.03 earnings per share.

A number of research analysts have recently weighed in on the company. Zacks Investment Research raised RTI Surgical from a “hold” rating to a “buy” rating and set a $6.25 price objective on the stock in a report on Wednesday, June 28th. ValuEngine raised RTI Surgical from a “sell” rating to a “hold” rating in a report on Friday, June 2nd. Finally, TheStreet raised RTI Surgical from a “d+” rating to a “c-” rating in a report on Friday, May 5th.

Shares of RTI Surgical (RTIX) remained flat at $5.65 on Tuesday. The stock had a trading volume of 206,605 shares. RTI Surgical has a 52-week low of $2.50 and a 52-week high of $5.95. The firm’s market cap is $328.41 million. The stock has a 50-day moving average price of $5.18 and a 200 day moving average price of $4.02.

In other news, EVP Kevin D. Brandt acquired 33,130 shares of the business’s stock in a transaction dated Wednesday, May 3rd. The shares were acquired at an average cost of $4.52 per share, with a total value of $149,747.60. Following the completion of the acquisition, the executive vice president now owns 126,215 shares of the company’s stock, valued at $570,491.80. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO Camille Farhat acquired 61,693 shares of the business’s stock in a transaction dated Thursday, May 18th. The stock was purchased at an average cost of $4.65 per share, for a total transaction of $286,872.45. The disclosure for this purchase can be found here. Insiders bought 112,023 shares of company stock worth $514,421 over the last three months. Corporate insiders own 4.90% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in RTIX. Nine Chapters Capital Management LLC raised its position in shares of RTI Surgical by 75.9% in the first quarter. Nine Chapters Capital Management LLC now owns 35,000 shares of the medical equipment provider’s stock worth $140,000 after buying an additional 15,100 shares in the last quarter. American International Group Inc. raised its position in shares of RTI Surgical by 7.0% in the first quarter. American International Group Inc. now owns 35,371 shares of the medical equipment provider’s stock worth $141,000 after buying an additional 2,327 shares in the last quarter. Bank of America Corp DE increased its stake in shares of RTI Surgical by 6.4% in the first quarter. Bank of America Corp DE now owns 39,786 shares of the medical equipment provider’s stock worth $159,000 after buying an additional 2,389 shares during the last quarter. TFS Capital LLC increased its stake in shares of RTI Surgical by 42.6% in the first quarter. TFS Capital LLC now owns 42,132 shares of the medical equipment provider’s stock worth $169,000 after buying an additional 12,587 shares during the last quarter. Finally, Ameriprise Financial Inc. increased its stake in shares of RTI Surgical by 29.5% in the first quarter. Ameriprise Financial Inc. now owns 44,807 shares of the medical equipment provider’s stock worth $180,000 after buying an additional 10,215 shares during the last quarter. 68.74% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: “Zacks: Analysts Anticipate RTI Surgical, Inc. (NASDAQ:RTIX) Will Announce Earnings of $0.01 Per Share” was originally published by American Banking News and is the property of of American Banking News. If you are viewing this news story on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2017/07/11/zacks-analysts-anticipate-rti-surgical-inc-nasdaqrtix-will-announce-earnings-of-0-01-per-share.html.

About RTI Surgical

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Get a free copy of the Zacks research report on RTI Surgical (RTIX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.